A successful treatment of severe systemic lupus erythematosus caused by occult pulmonary infection-associated with hemophagocytic syndrome: A case report.
Identifieur interne : 000110 ( PubMed/Curation ); précédent : 000109; suivant : 000111A successful treatment of severe systemic lupus erythematosus caused by occult pulmonary infection-associated with hemophagocytic syndrome: A case report.
Auteurs : Weihong Shi ; Mingyang Duan [République populaire de Chine] ; Ligang Jie ; Weifeng SunSource :
- Medicine [ 1536-5964 ] ; 2018.
Descripteurs français
- KwdFr :
- Adulte, Antibactériens (administration et posologie), Antirhumatismaux (administration et posologie), Cilastatine (administration et posologie), Femelle, Humains, Hydroxychloroquine (administration et posologie), Imipénem (administration et posologie), Lupus érythémateux disséminé (), Lupus érythémateux disséminé (diagnostic), Lupus érythémateux disséminé (traitement médicamenteux), Lymphohistiocytose hémophagocytaire (diagnostic), Lymphohistiocytose hémophagocytaire (immunologie), Lymphohistiocytose hémophagocytaire (traitement médicamenteux), Lymphohistiocytose hémophagocytaire (étiologie), Myélogramme (), Numération formule sanguine (), Pneumopathie infectieuse (), Pneumopathie infectieuse (diagnostic), Pneumopathie infectieuse (immunologie), Pneumopathie infectieuse (traitement médicamenteux), Poumon (imagerie diagnostique), Prednisolone (administration et posologie), Résultat thérapeutique, Tomodensitométrie ().
- MESH :
- administration et posologie : Antibactériens, Antirhumatismaux, Cilastatine, Hydroxychloroquine, Imipénem, Prednisolone.
- diagnostic : Lupus érythémateux disséminé, Lymphohistiocytose hémophagocytaire, Pneumopathie infectieuse.
- imagerie diagnostique : Poumon.
- immunologie : Lymphohistiocytose hémophagocytaire, Pneumopathie infectieuse.
- traitement médicamenteux : Lupus érythémateux disséminé, Lymphohistiocytose hémophagocytaire, Pneumopathie infectieuse.
- étiologie : Lymphohistiocytose hémophagocytaire.
- Adulte, Femelle, Humains, Lupus érythémateux disséminé, Myélogramme, Numération formule sanguine, Pneumopathie infectieuse, Résultat thérapeutique, Tomodensitométrie.
English descriptors
- KwdEn :
- Adult, Anti-Bacterial Agents (administration & dosage), Antirheumatic Agents (administration & dosage), Blood Cell Count (methods), Bone Marrow Examination (methods), Cilastatin (administration & dosage), Female, Humans, Hydroxychloroquine (administration & dosage), Imipenem (administration & dosage), Lung (diagnostic imaging), Lupus Erythematosus, Systemic (complications), Lupus Erythematosus, Systemic (diagnosis), Lupus Erythematosus, Systemic (drug therapy), Lymphohistiocytosis, Hemophagocytic (diagnosis), Lymphohistiocytosis, Hemophagocytic (drug therapy), Lymphohistiocytosis, Hemophagocytic (etiology), Lymphohistiocytosis, Hemophagocytic (immunology), Pneumonia (complications), Pneumonia (diagnosis), Pneumonia (drug therapy), Pneumonia (immunology), Prednisolone (administration & dosage), Tomography, X-Ray Computed (methods), Treatment Outcome.
- MESH :
- chemical , administration & dosage : Anti-Bacterial Agents, Antirheumatic Agents, Cilastatin, Hydroxychloroquine, Imipenem, Prednisolone.
- complications : Lupus Erythematosus, Systemic, Pneumonia.
- diagnosis : Lupus Erythematosus, Systemic, Lymphohistiocytosis, Hemophagocytic, Pneumonia.
- diagnostic imaging : Lung.
- drug therapy : Lupus Erythematosus, Systemic, Lymphohistiocytosis, Hemophagocytic, Pneumonia.
- etiology : Lymphohistiocytosis, Hemophagocytic.
- immunology : Lymphohistiocytosis, Hemophagocytic, Pneumonia.
- methods : Blood Cell Count, Bone Marrow Examination, Tomography, X-Ray Computed.
- Adult, Female, Humans, Treatment Outcome.
Abstract
A 27-year-old woman with a history of systemic lupus erythaematosus (SLE) developed hemophagocytic syndrome (HPS) secondary due to an unrecognized infection that led to severe SLE with a prolonged recovery.
DOI: 10.1097/MD.0000000000010595
PubMed: 29742693
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000110
Links to Exploration step
pubmed:29742693Curation
No country items
Weihong Shi<affiliation><nlm:affiliation>Department of Chinese Medicine, Guangzhou General Hospital of Guangzhou Military Command.</nlm:affiliation><wicri:noCountry code="subField">Guangzhou General Hospital of Guangzhou Military Command</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Department of Chinese Medicine, Guangzhou General Hospital of Guangzhou Military Command.</nlm:affiliation><wicri:noCountry code="subField">Guangzhou General Hospital of Guangzhou Military Command</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Department of Chinese Medicine, Guangzhou General Hospital of Guangzhou Military Command.</nlm:affiliation><wicri:noCountry code="subField">Guangzhou General Hospital of Guangzhou Military Command</wicri:noCountry></affiliation>Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A successful treatment of severe systemic lupus erythematosus caused by occult pulmonary infection-associated with hemophagocytic syndrome: A case report.</title><author><name sortKey="Shi, Weihong" sort="Shi, Weihong" uniqKey="Shi W" first="Weihong" last="Shi">Weihong Shi</name><affiliation><nlm:affiliation>Department of Chinese Medicine, Guangzhou General Hospital of Guangzhou Military Command.</nlm:affiliation><wicri:noCountry code="subField">Guangzhou General Hospital of Guangzhou Military Command</wicri:noCountry></affiliation></author><author><name sortKey="Duan, Mingyang" sort="Duan, Mingyang" uniqKey="Duan M" first="Mingyang" last="Duan">Mingyang Duan</name><affiliation wicri:level="1"><nlm:affiliation>Guangzhou University of Chinese Medicine, Guangzhou, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Guangzhou University of Chinese Medicine, Guangzhou</wicri:regionArea></affiliation></author><author><name sortKey="Jie, Ligang" sort="Jie, Ligang" uniqKey="Jie L" first="Ligang" last="Jie">Ligang Jie</name><affiliation><nlm:affiliation>Department of Chinese Medicine, Guangzhou General Hospital of Guangzhou Military Command.</nlm:affiliation><wicri:noCountry code="subField">Guangzhou General Hospital of Guangzhou Military Command</wicri:noCountry></affiliation></author><author><name sortKey="Sun, Weifeng" sort="Sun, Weifeng" uniqKey="Sun W" first="Weifeng" last="Sun">Weifeng Sun</name><affiliation><nlm:affiliation>Department of Chinese Medicine, Guangzhou General Hospital of Guangzhou Military Command.</nlm:affiliation><wicri:noCountry code="subField">Guangzhou General Hospital of Guangzhou Military Command</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:29742693</idno><idno type="pmid">29742693</idno><idno type="doi">10.1097/MD.0000000000010595</idno><idno type="wicri:Area/PubMed/Corpus">000110</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000110</idno><idno type="wicri:Area/PubMed/Curation">000110</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000110</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A successful treatment of severe systemic lupus erythematosus caused by occult pulmonary infection-associated with hemophagocytic syndrome: A case report.</title><author><name sortKey="Shi, Weihong" sort="Shi, Weihong" uniqKey="Shi W" first="Weihong" last="Shi">Weihong Shi</name><affiliation><nlm:affiliation>Department of Chinese Medicine, Guangzhou General Hospital of Guangzhou Military Command.</nlm:affiliation><wicri:noCountry code="subField">Guangzhou General Hospital of Guangzhou Military Command</wicri:noCountry></affiliation></author><author><name sortKey="Duan, Mingyang" sort="Duan, Mingyang" uniqKey="Duan M" first="Mingyang" last="Duan">Mingyang Duan</name><affiliation wicri:level="1"><nlm:affiliation>Guangzhou University of Chinese Medicine, Guangzhou, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Guangzhou University of Chinese Medicine, Guangzhou</wicri:regionArea></affiliation></author><author><name sortKey="Jie, Ligang" sort="Jie, Ligang" uniqKey="Jie L" first="Ligang" last="Jie">Ligang Jie</name><affiliation><nlm:affiliation>Department of Chinese Medicine, Guangzhou General Hospital of Guangzhou Military Command.</nlm:affiliation><wicri:noCountry code="subField">Guangzhou General Hospital of Guangzhou Military Command</wicri:noCountry></affiliation></author><author><name sortKey="Sun, Weifeng" sort="Sun, Weifeng" uniqKey="Sun W" first="Weifeng" last="Sun">Weifeng Sun</name><affiliation><nlm:affiliation>Department of Chinese Medicine, Guangzhou General Hospital of Guangzhou Military Command.</nlm:affiliation><wicri:noCountry code="subField">Guangzhou General Hospital of Guangzhou Military Command</wicri:noCountry></affiliation></author></analytic><series><title level="j">Medicine</title><idno type="eISSN">1536-5964</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Anti-Bacterial Agents (administration & dosage)</term><term>Antirheumatic Agents (administration & dosage)</term><term>Blood Cell Count (methods)</term><term>Bone Marrow Examination (methods)</term><term>Cilastatin (administration & dosage)</term><term>Female</term><term>Humans</term><term>Hydroxychloroquine (administration & dosage)</term><term>Imipenem (administration & dosage)</term><term>Lung (diagnostic imaging)</term><term>Lupus Erythematosus, Systemic (complications)</term><term>Lupus Erythematosus, Systemic (diagnosis)</term><term>Lupus Erythematosus, Systemic (drug therapy)</term><term>Lymphohistiocytosis, Hemophagocytic (diagnosis)</term><term>Lymphohistiocytosis, Hemophagocytic (drug therapy)</term><term>Lymphohistiocytosis, Hemophagocytic (etiology)</term><term>Lymphohistiocytosis, Hemophagocytic (immunology)</term><term>Pneumonia (complications)</term><term>Pneumonia (diagnosis)</term><term>Pneumonia (drug therapy)</term><term>Pneumonia (immunology)</term><term>Prednisolone (administration & dosage)</term><term>Tomography, X-Ray Computed (methods)</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Antibactériens (administration et posologie)</term><term>Antirhumatismaux (administration et posologie)</term><term>Cilastatine (administration et posologie)</term><term>Femelle</term><term>Humains</term><term>Hydroxychloroquine (administration et posologie)</term><term>Imipénem (administration et posologie)</term><term>Lupus érythémateux disséminé ()</term><term>Lupus érythémateux disséminé (diagnostic)</term><term>Lupus érythémateux disséminé (traitement médicamenteux)</term><term>Lymphohistiocytose hémophagocytaire (diagnostic)</term><term>Lymphohistiocytose hémophagocytaire (immunologie)</term><term>Lymphohistiocytose hémophagocytaire (traitement médicamenteux)</term><term>Lymphohistiocytose hémophagocytaire (étiologie)</term><term>Myélogramme ()</term><term>Numération formule sanguine ()</term><term>Pneumopathie infectieuse ()</term><term>Pneumopathie infectieuse (diagnostic)</term><term>Pneumopathie infectieuse (immunologie)</term><term>Pneumopathie infectieuse (traitement médicamenteux)</term><term>Poumon (imagerie diagnostique)</term><term>Prednisolone (administration et posologie)</term><term>Résultat thérapeutique</term><term>Tomodensitométrie ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-Bacterial Agents</term><term>Antirheumatic Agents</term><term>Cilastatin</term><term>Hydroxychloroquine</term><term>Imipenem</term><term>Prednisolone</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antibactériens</term><term>Antirhumatismaux</term><term>Cilastatine</term><term>Hydroxychloroquine</term><term>Imipénem</term><term>Prednisolone</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Lupus Erythematosus, Systemic</term><term>Pneumonia</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lupus Erythematosus, Systemic</term><term>Lymphohistiocytosis, Hemophagocytic</term><term>Pneumonia</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Lupus érythémateux disséminé</term><term>Lymphohistiocytose hémophagocytaire</term><term>Pneumopathie infectieuse</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Lung</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lupus Erythematosus, Systemic</term><term>Lymphohistiocytosis, Hemophagocytic</term><term>Pneumonia</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphohistiocytosis, Hemophagocytic</term></keywords><keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Poumon</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Lymphohistiocytose hémophagocytaire</term><term>Pneumopathie infectieuse</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Lymphohistiocytosis, Hemophagocytic</term><term>Pneumonia</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Blood Cell Count</term><term>Bone Marrow Examination</term><term>Tomography, X-Ray Computed</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Lupus érythémateux disséminé</term><term>Lymphohistiocytose hémophagocytaire</term><term>Pneumopathie infectieuse</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphohistiocytose hémophagocytaire</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Female</term><term>Humans</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Femelle</term><term>Humains</term><term>Lupus érythémateux disséminé</term><term>Myélogramme</term><term>Numération formule sanguine</term><term>Pneumopathie infectieuse</term><term>Résultat thérapeutique</term><term>Tomodensitométrie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A 27-year-old woman with a history of systemic lupus erythaematosus (SLE) developed hemophagocytic syndrome (HPS) secondary due to an unrecognized infection that led to severe SLE with a prolonged recovery.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29742693</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><Issue>19</Issue><PubDate><Year>2018</Year><Month>May</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>A successful treatment of severe systemic lupus erythematosus caused by occult pulmonary infection-associated with hemophagocytic syndrome: A case report.</ArticleTitle><Pagination><MedlinePgn>e0595</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000010595</ELocationID><Abstract><AbstractText Label="RATIONALE" NlmCategory="BACKGROUND">A 27-year-old woman with a history of systemic lupus erythaematosus (SLE) developed hemophagocytic syndrome (HPS) secondary due to an unrecognized infection that led to severe SLE with a prolonged recovery.</AbstractText><AbstractText Label="PATIENT CONCERNS" NlmCategory="UNASSIGNED">The patient showed a high spiking fever and myalgia. Laboratory data revealed pancytopenia and immunological abnormalities. Pulse methylprednisone plus intravenous immunoglobulin (IVIG) failed to improve the clinical symptoms and laboratory data.</AbstractText><AbstractText Label="DIAGNOSES" NlmCategory="UNASSIGNED">As activated macrophages with hemophagocytosis were confirmed in bone marrow histology, the patient was diagnosed as having reactive HPS.</AbstractText><AbstractText Label="INTERVENTIONS AND OUTCOMES" NlmCategory="RESULTS">Her reactive HPS was successfully treated with intravenous antibiotics and was followed by oral prednisolone and hydroxychloroquine maintenance therapy.</AbstractText><AbstractText Label="LESSONS" NlmCategory="CONCLUSIONS">In severe SLE, patients with persistent high fever, cytopenia, and elevated levels of serum ferritin and liver enzymes should be strongly suspected of reactive HPS, and aggressive examination, such as bone marrow biopsy, needs to be considered for early diagnosis and proper treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Weihong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Chinese Medicine, Guangzhou General Hospital of Guangzhou Military Command.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Mingyang</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jie</LastName><ForeName>Ligang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Chinese Medicine, Guangzhou General Hospital of Guangzhou Military Command.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Weifeng</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Chinese Medicine, Guangzhou General Hospital of Guangzhou Military Command.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>141A6AMN38</RegistryNumber><NameOfSubstance UI="D015377">Cilastatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>71OTZ9ZE0A</RegistryNumber><NameOfSubstance UI="D015378">Imipenem</NameOfSubstance></Chemical><Chemical><RegistryNumber>9PHQ9Y1OLM</RegistryNumber><NameOfSubstance UI="D011239">Prednisolone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001772" MajorTopicYN="N">Blood Cell Count</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001856" MajorTopicYN="N">Bone Marrow Examination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015377" MajorTopicYN="N">Cilastatin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015378" MajorTopicYN="N">Imipenem</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051359" MajorTopicYN="Y">Lymphohistiocytosis, Hemophagocytic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="Y">Pneumonia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011239" MajorTopicYN="N">Prednisolone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29742693</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000010595</ArticleId><ArticleId IdType="pii">00005792-201805110-00012</ArticleId><ArticleId IdType="pmc">PMC5959410</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blood Rev. 2014 Jul;28(4):135-42</Citation><ArticleIdList><ArticleId IdType="pubmed">24792320</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Blood Cancer. 2008 Sep;51(3):402-4</Citation><ArticleIdList><ArticleId IdType="pubmed">18523990</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2003 May;30(5):1027-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12734900</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pediatr. 2007 Feb;166(2):95-109</Citation><ArticleIdList><ArticleId IdType="pubmed">17151879</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Rheumatol. 2012 Jan;24(1):113-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22089101</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2000 Nov-Dec;6(6):601-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11076718</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2007 Dec;7(12):814-22</Citation><ArticleIdList><ArticleId IdType="pubmed">18045564</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Hematol. 1997 Aug;66(2):135-51</Citation><ArticleIdList><ArticleId IdType="pubmed">9277044</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Rheumatol. 2003 Sep;15(5):587-90</Citation><ArticleIdList><ArticleId IdType="pubmed">12960485</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Crit Care Med. 2009 May;10(3):387-92</Citation><ArticleIdList><ArticleId IdType="pubmed">19325510</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000110 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000110 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:29742693
|texte= A successful treatment of severe systemic lupus erythematosus caused by occult pulmonary infection-associated with hemophagocytic syndrome: A case report.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:29742693" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |